Compile Data Set for Download or QSAR
Report error Found 100 Enz. Inhib. hit(s) with all data for entry = 1741
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13863(N,1-bis[(3-carbamimidoylphenyl)methyl]-4-methyl-1H...)
Affinity DataKi:  7nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13866(N,1-bis[(3-carbamimidoylphenyl)methyl]-4-hydroxy-1...)
Affinity DataKi:  9nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13825(N,1-bis[(3-carbamimidoylphenyl)methyl]-3-chloro-1H...)
Affinity DataKi:  9nM ΔG°:  -45.9kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13861(1-[(3-carbamimidoylphenyl)methyl]-N-[(3,5-dimethyl...)
Affinity DataKi:  9nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13862(CHEMBL307196 | 1-[(3-carbamimidoylphenyl)methyl]-N...)
Affinity DataKi:  11nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13880(1-[(3-carbamimidoylphenyl)methyl]-4-hydroxy-N-{[3-...)
Affinity DataKi:  13nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13820(3-bromo-1-[(3-carbamimidoylphenyl)methyl]-N-[(3,5-...)
Affinity DataKi:  13nM ΔG°:  -45.0kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13898(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  14nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13869(N,1-bis[(3-carbamimidoylphenyl)methyl]-1H-indole-2...)
Affinity DataKi:  19nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13885(2,2,2-trifluoroacetate; N-benzyl-4-[({1-[(3-carbam...)
Affinity DataKi:  23nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13837(1-[(3-carbamimidoylphenyl)methyl]-N-[(1-carbamimid...)
Affinity DataKi:  25nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM12402(1-[(3-carbamimidoylphenyl)methyl]-N-[(3,5-dichloro...)
Affinity DataKi:  25nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13822(3-bromo-N,1-bis[(3-carbamimidoylphenyl)methyl]-1H-...)
Affinity DataKi:  26nM ΔG°:  -43.3kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13897(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  28nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13874(1-[(3-carbamimidoylphenyl)methyl]-N-{[3-fluoro-5-(...)
Affinity DataKi:  39nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13826(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  40nM ΔG°:  -42.2kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13877(1-[(3-carbamimidoylphenyl)methyl]-4-hydroxy-N-[(3-...)
Affinity DataKi:  42nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13821(3-bromo-N,1-bis[(3-carbamimidoylphenyl)methyl]-4-m...)
Affinity DataKi:  50nM ΔG°:  -41.7kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13838(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  50nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13865(5-amino-N,1-bis[(3-carbamimidoylphenyl)methyl]-1H-...)
Affinity DataKi:  51nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13864((3-carbamimidoylphenyl)methyl 5-(benzyloxy)-1-[(3-...)
Affinity DataKi:  61nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13893(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  62nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13895(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  66nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13840(1-[(3-carbamimidoylphenyl)methyl]-4-hydroxy-N-(nap...)
Affinity DataKi:  68nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13890(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  76nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13867(N,1-bis[(3-carbamimidoylphenyl)methyl]-5-hydroxy-1...)
Affinity DataKi:  77nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13894(2,2,2-trifluoroacetate; 4-({[5-(benzyloxy)-1-[(3-c...)
Affinity DataKi:  82nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13819(3-bromo-1-[(3-carbamimidoylphenyl)methyl]-N-[(3,5-...)
Affinity DataKi:  85nM ΔG°:  -40.4kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13891(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  90nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13834(2,2,2-trifluoroacetate; 4-[(1S)-1-({1-[(3-carbamim...)
Affinity DataKi:  92nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13839(1-[(3-carbamimidoylphenyl)methyl]-4-methyl-N-(naph...)
Affinity DataKi:  96nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13856(N-{[3,5-bis(trifluoromethyl)phenyl]methyl}-1-[(3-c...)
Affinity DataKi:  99nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13850(1-[(3-carbamimidoylphenyl)methyl]-4-hydroxy-N-[(2,...)
Affinity DataKi:  99nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13832(2,2,2-trifluoroacetate; 4-[({5-amino-1-[(3-carbami...)
Affinity DataKi:  100nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13888(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  103nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13833(2,2,2-trifluoroacetate; 4-{4-[({1-[(3-carbamimidoy...)
Affinity DataKi:  110nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13870(N-[(3-bromophenyl)methyl]-1-[(3-carbamimidoylpheny...)
Affinity DataKi:  117nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13881(1-[(3-carbamimidoylphenyl)methyl]-4-hydroxy-N-[(3-...)
Affinity DataKi:  131nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13868(5-(benzyloxy)-N,1-bis[(3-carbamimidoylphenyl)methy...)
Affinity DataKi:  133nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13896(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  140nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13889(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  141nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13899(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  144nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13831(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  150nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13828(2,2,2-trifluoroacetate; 4-[1-({1-[(3-carbamimidoyl...)
Affinity DataKi:  160nM ΔG°:  -38.8kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13817(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  170nM ΔG°:  -38.6kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13823(2,2,2-trifluoroacetate; 4-[({1-[(3-carbamimidoylph...)
Affinity DataKi:  170nM ΔG°:  -38.6kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13871(1-[(3-carbamimidoylphenyl)methyl]-N-{[3-(carbamoyl...)
Affinity DataKi:  180nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13859(1-[(3-carbamimidoylphenyl)methyl]-N-[(3,5-difluoro...)
Affinity DataKi:  191nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13860(1-[(3-carbamimidoylphenyl)methyl]-N-[(3,5-dimethox...)
Affinity DataKi:  193nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13872(1-[(3-carbamimidoylphenyl)methyl]-N-[(3-carbamoylp...)
Affinity DataKi:  240nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2007
Entry Details Article
PubMed
Displayed 1 to 50 (of 100 total ) | Next | Last >>
Jump to: